Hunter C Smith insider trades: Rhythm Pharmaceuticals (RYTM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hunter reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | RYTM | ↓ Sell | 62,774 | $105.46 | $6.6M | Direct | Sep 1, 2026 (1d) |
| Feb 19, 2026 | RYTM | ↓ Sell | 7,954 | $101.31 | $806K | Direct | Feb 19, 2026 (0d) |
| Feb 12, 2026 | RYTM | ↓ Sell | 7,071 | $100.21 | $709K | Direct | Feb 12, 2026 (0d) |
| Feb 5, 2026 | RYTM | ↓ Sell | 6,628 | $106.03 | $703K | Direct | Feb 6, 2026 (1d) |
| Aug 13, 2025 | RYTM | ↓ Sell | 28,088 | $96.29 | $2.7M | Direct | Aug 14, 2025 (1d) |
| Jul 9, 2025 | RYTM | ↓ Sell | 42,120 | $80.48 | $3.4M | Direct | Jul 11, 2025 (2d) |
| May 30, 2025 | RYTM | ↓ Sell | 23,400 | $61.41 | $1.4M | Direct | Jun 3, 2025 (4d) |
| Feb 19, 2025 | RYTM | ↓ Sell | 2,215 | $57.22 | $127K | Direct | Feb 19, 2025 (0d) |
| Feb 12, 2025 | RYTM | ↓ Sell | 751 | $56.39 | $42K | Direct | Feb 14, 2025 (2d) |
| Feb 11, 2025 | RYTM | ↓ Sell | 1,296 | $57.51 | $75K | Direct | Feb 11, 2025 (0d) |
| Feb 4, 2025 | RYTM | ↓ Sell | 1,678 | $59.43 | $100K | Direct | Feb 4, 2025 (0d) |
| Mar 19, 2024 | RYTM | ↓ Sell | 15,515 | $39.22 | $608K | Direct | Mar 19, 2024 (0d) |
| Feb 13, 2024 | RYTM | ↓ Sell | 1,918 | $50.80 | $97K | Direct | Feb 13, 2024 (0d) |
| Feb 1, 2024 | RYTM | ↓ Sell | 1,616 | $45.06 | $73K | Direct | Feb 5, 2024 (4d) |
| Dec 6, 2023 | RYTM | ↓ Sell | 27,026 | $38.72 | $1.0M | Direct | Dec 7, 2023 (1d) |
| Nov 24, 2023 | RYTM | ↓ Sell | 10,974 | $35.02 | $384K | Direct | Nov 28, 2023 (4d) |
| Nov 14, 2023 | RYTM | ↓ Sell | 12,000 | $30.38 | $365K | Direct | Nov 16, 2023 (2d) |
| Feb 14, 2023 | RYTM | ↓ Sell | 702 | $26.87 | $19K | Direct | Feb 14, 2023 (0d) |
| Feb 9, 2023 | RYTM | ↓ Sell | 1,398 | $27.66 | $39K | Direct | Feb 13, 2023 (4d) |
| Jul 1, 2022 | RYTM | ↓ Sell | 7,547 | $4.08 | $31K | Direct | Jul 6, 2022 (5d) |
| Feb 15, 2022 | RYTM | ↓ Sell | 833 | $6.10 | $5K | Direct | Feb 15, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RYTM insiders
Open-market trades in the last 12 months
About Hunter C Smith's insider trades
Hunter C Smith is Chief Financial Officer at Rhythm Pharmaceuticals (RYTM). Since Feb 15, 2022, Hunter has reported no open-market purchases and 21 sales worth $19.4M on SEC Form 4. In the last 12 months: 4 sales ($8.8M).
Their filings also include grants and awards (38 filings), option exercises (30 filings), shares withheld for taxes (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.